Sight Sciences Insider Sales 因为季度亏损超过预期。 Sight Sciences Insider Sales As Quarterly Loss Exceeds Estimates.

SightScience, Inc. (NASDAQ:SGHT)报告,季度收入损失为每股0.25美元,超过估计,收入为2 137万美元。 Sight Sciences, Inc. (NASDAQ: SGHT) reported a quarterly earnings loss of $0.25 per share, exceeding estimates, with revenues of $21.37 million. 10月1日,内部人士杰里米·海登以29658.24美元的价格出售了4878股股票,而CFO艾莉森·巴尔莱恩则出售了10130股股票. On October 1, insider Jeremy B. Hayden sold 4,878 shares for $29,658.24, while CFO Alison Bauerlein sold 10,130 shares. 该公司专业生产眼科医疗器械,市值为2.98亿美元, 分析师评价为"持有", 目标价为7.25美元. The company, specializing in ophthalmic medical devices, has a market cap of $298.54 million and is rated "Hold" by analysts, with a target price of $7.25.